Amanote Research

Amanote Research

    RegisterSign In

MS20.03 Immunotherapy and Surgery: Neoadjuvant or Adjuvant? Is It Safe?

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.170
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineOncologyRespiratory MedicinePulmonary
Date

October 1, 2018

Authors
J. Chaft
Publisher

Elsevier BV


Related search

Bariatric Surgery in Cirrhotic Patients: Is It Safe?

Obesity Surgery
NutritionEndocrinologyDieteticsSurgeryMetabolismDiabetes
2019English

Is It Safe?

2009English

Definitive Surgery During Acute Phase of Chronic Pancreatitis – Is It Safe?

HPB
HepatologyGastroenterology
2016English

Neoadjuvant Immunotherapy: Is This the “New” Induction Chemotherapy?

British Journal of Oral and Maxillofacial Surgery
OtorhinolaryngologyOral SurgerySurgery
2019English

Disinfected So It Is Safe and Works

Journal of diabetes science and technology
Internal MedicineEndocrinologyBioengineeringBiomedical EngineeringMetabolismDiabetes
2011English

Fungus or Cancer: Is It or Is It Not?

Archives in Biomedical Engineering & Biotechnology
2019English

Is It or Is It Not a Pathogenic Mutation? Is It or Is It Not the Podocyte?

Journal of Nephropathology
Nephrology
2012English

Adjuvant and Neoadjuvant Treatment of Melanoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

Neoadjuvant or Adjuvant Sirolimus for Malignant Metastatic or Locally Advanced Perivascular Epithelioid Cell Tumors

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy